HORIBA joins new consortium to accelerate technology development and potentially lower cost in cell and gene therapy manufacturing

The consortium will assess multiple new or existing process analytical technologies (PAT), including HORIBA’s A-TEEM™ fluorescence technology HORIBA announces its participation in a new consortium formed to accelerate the development of process analytical technologies (PAT) in cell and gene therapy manufacturing. HORIBA’s new A-TEEM™ Molecular Fingerprinting technology has shown great...

NHS LINCOLNSHIRE SUSTAINABILITY AND TRANSFORMATION PARTNERSHIP APPOINTS SPIRIT DIGITAL TO UNDERPIN ITS ‘VIRTUAL WARD’ AND DOMICILIARY CARE INITIATIVE

Spirit’s CliniTouch Vie Digital Telehealth Offering to support NHS Lincolnshire’s Remote Monitoring Transformation Strategy NHS Lincolnshire STP has appointed Spirit Digital to implement its Virtual Ward and Domiciliary Care initiative through Spirit’s CliniTouch Vie digital remote monitoring platform. As part of NHS Lincolnshire’s wider Remote Monitoring strategy, CliniTouch Vie will...

TCC-CASEMIX SECURES SURGICAL TRANSFORMATION JOINT WORKING AGREEMENT WITH THE NORTHERN CARE ALLIANCE NHS GROUP

Spin-off business, from The Conclude Consultancy, TCC-CASEMIX has been appointed to lead ‘Project Meteor’, a transformation programme to drive 20% improvement in surgical productivity. A year after winning the Innovate UK SMART Grant, one of the UK’s most prestigeous and competitive grant awards [3-5% success rate], TCC-CASEMIX brings to market...

Double Winners at the Medilink Midlands Business Awards

6 life science companies from the West Midlands and 6 from the East Midlands were delighted to be selected as winners at yesterday’s Medilink Midlands Business Awards, which saw over 130 businesspeople from life science companies across the region and beyond come together online to celebrate and reflect on the...

Innovation boost for Harlow businesses

Arise will provide unique foundation for highly innovative companies   Dr Beverley Vaughan has been announced as director of the new innovation hub, Arise. The hub, which is funded by Anglia Ruskin University (ARU), and Essex County Council, will support innovative companies and entrepreneurs in Harlow to grow their businesses....

CHARNWOOD MOLECULAR COMBINES DISCOVERY BIOLOGY WITH MEDICINAL CHEMISTRY THROUGH THE ACQUISTION OF AURELIA BIOSCIENCE LTD.

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, is pleased to announce the acquisition of the assay development and biological screening provider, Aurelia Bioscience. The sector-leading expertise and technology development within Aurelia Bioscience will enable and enhance Charnwood’s provision of a world-class integrated...

Sygnature Discovery expands into early CMC development

Sygnature has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. Located at our headquarters in Nottingham, UK, the new service line will expand our offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials. With over £1m of capital investment...